Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05658120

Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery

Conditions: Postperfusion Syndrome

Sex: All
Ages: 18 Years – 80 Years
Enrollment: 246
Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Location: Spain

Summary

The incidence of postreperfusion syndrome (PRS) and vasoplegic syndrome (VS) is unknown, and occasionally can be confused since these syndromes share some hemodynamic characteristics. In these cases, monitoring with Swan Ganz catheter may be useful to make the differential diagnosis. The main outcome was to determine the incidence and prognosis of patients with PRS and VS

Eligibility Criteria

Inclusion Criteria: Consecutive patients ≥ 18 years-old, who underwent liver transplant surgery, monitored with Swan-Ganz catheter, with norepinephrine/adrenaline support during transplant surgeryExclusion Criteria:Acute liver failure, combined liver/kidney transplantation, re-transplantation, living-donor related transplantation, moderate to severe vascular and valvular heart disease, chronic kidney disease (serum creatinine > 1.5), moderate and sever hepato-pulmonary syndrome, moderate and sever porto-pulmonary syndrome

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05658120). StuddyBuddy aggregates publicly available trial information.